Group 1 - The core viewpoint of the article highlights the continuous improvement in drug safety and the high-quality development of the pharmaceutical industry in the province, with a significant increase in the number of production enterprises [1] - By the end of 2025, the province had a total of 2,618 "two products and one device" (drugs, cosmetics, and medical devices) production enterprises, representing a 53% increase compared to 2020 [1] - The drug safety inspection pass rate remains above 99%, with no major drug safety incidents reported [1] Group 2 - In 2025, the province approved 107 new drug approval numbers, with 60 new varieties passing the consistency evaluation for generic drugs [2] - The first class 1 innovative drug "Azvudine tablets" and the first antibody drug "Bevacizumab injection" were approved during the "14th Five-Year Plan" period [2] - The provincial drug regulatory authority aims to create a new ecosystem for pharmaceutical industry development through five major actions, focusing on political guidance, reform innovation, drug safety, industry ecology, and regulatory capacity enhancement [2]
医药产业高质量发展显成效 全省“两品一械”生产企业超2600家
He Nan Ri Bao·2026-02-06 23:11